We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+10.45%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.29B
AUM Growth
-$264M
Cap. Flow
-$511M
Cap. Flow %
-15.51%
Top 10 Hldgs %
40.48%
Holding
97
New
23
Increased
21
Reduced
21
Closed
30

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$102M
2
AMZN icon
Amazon
AMZN
+$92.7M
3
SCHW
Charles Schwab
SCHW
+$88M
4
BABA icon
Alibaba
BABA
+$82.5M
5
SYF icon
Synchrony
SYF
+$61.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$166M
2
UNH icon
UnitedHealth
UNH
+$151M
3
HCA icon
HCA Healthcare
HCA
+$137M
4
GILD icon
Gilead Sciences
GILD
+$110M
5
LLY icon
Eli Lilly
LLY
+$92.6M

Sector Composition

Rank Sector Weight
1 Healthcare 48.02%
2 Technology 9.28%
3 Industrials 8.23%
4 Financials 7.66%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
51
DexCom
DXCM
$29B
$14.4M 0.44%
+704,152
New +$14.7M
MCK icon
52
McKesson
MCK
$104B
$14.3M 0.44%
+72,627
New +$13.7M
KURA icon
53
Kura Oncology
KURA
$793M
$12.6M 0.38%
+1,494,169
New +$11.8M
CLVS
54
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$11.4M 0.35%
+325,100
New +$21M
MYOK
55
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$10.2M 0.31%
+698,694
New +$8.55M
AMAG
56
DELISTED
AMAG Pharmaceuticals
AMAG
$8.53M 0.26%
+282,420
New +$9.12M
DMTX
57
DELISTED
Dimension Therapeutics, Inc
DMTX
$8.38M 0.25%
+815,359
New +$10.3M
GILD icon
58
Gilead Sciences
GILD
$165B
$6.7M 0.2%
66,187
-1,059,787
-94% -$110M
JUNO
59
DELISTED
Juno Therapeutics, Inc.
JUNO
$6.63M 0.2%
150,684
+77,053
+105% +$3.82M
CHRS icon
60
Coherus Oncology
CHRS
$217M
$3.96M 0.12%
172,638
-122,941
-42% -$3.16M
TEAM icon
61
Atlassian
TEAM
$26.5B
$2.96M 0.09%
+98,357
New +$2.8M
PEN icon
62
Penumbra
PEN
$12.6B
$2.5M 0.08%
46,531
-334,739
-88% -$15.2M
SAGE
63
DELISTED
Sage Therapeutics
SAGE
$2.38M 0.07%
+40,850
New +$2.02M
RGNX icon
64
Regenxbio
RGNX
$616M
$1.98M 0.06%
119,092
+11,787
+11% +$234K
MXL icon
65
MaxLinear
MXL
$5.19B
$1.2M 0.04%
81,443
+45
+0.1% +$677
ADAP
66
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-1,002,953
Closed -$12M
ALLY icon
67
Ally Financial
ALLY
$13.1B
– –
-2,348,383
Closed -$47.9M
BKNG icon
68
Booking.com
BKNG
$156B
– –
-1,146,950
Closed -$56.7M
DBVT
69
DBV Technologies
DBVT
$813M
– –
-27,397
Closed -$9.75M
EXP icon
70
Eagle Materials
EXP
$6.49B
– –
-586,800
Closed -$40.1M
GOOG icon
71
Alphabet (Google) Class C
GOOG
$4.11T
– –
-1,326,200
Closed -$42.3M
HUM icon
72
Humana
HUM
$43.9B
– –
-186,935
Closed -$33.5M
JD icon
73
JD.com
JD
$43.5B
– –
-1,693,324
Closed -$44.1M
LBTYK icon
74
Liberty Global Class C
LBTYK
$3.5B
– –
-784,471
Closed -$27.9M
LLY icon
75
Eli Lilly
LLY
$1.08T
– –
-1,106,139
Closed -$92.6M
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q4 2015 Portfolio in Review

As of Q4 2015, PFM Health Sciences held 97 positions worth $3.29B, down 7.4% from $3.55B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PFM Health Sciences withdrew a net $511M in Q4 2015, closing 30 positions and reducing 21 holdings. Its most notable exit was Pfizer, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 59% a quarter earlier, followed by Technology and Industrials.

Against the trend, PFM Health Sciences opened a new position in Alphabet (Google) Class A worth $107M.

  • PFM Health Sciences's largest Q4 2015 buy was Alphabet (Google) Class A: 2,750,720 shares worth $107M.
  • PFM Health Sciences added most to Bristol-Myers Squibb in Q4 2015, an estimated $51.4M increase.
  • PFM Health Sciences's biggest Q4 2015 reduction was UnitedHealth, cutting an estimated $151M.
  • PFM Health Sciences fully exited Pfizer in Q4 2015, selling an estimated $166M.
  • PFM Health Sciences's ten largest holdings make up 40% of its $3.29B portfolio in Q4 2015.
  • PFM Health Sciences opened 23 new positions and closed 30 in Q4 2015.
  • PFM Health Sciences's portfolio value fell 7.4% quarter-over-quarter to $3.29B.

Based on PFM Health Sciences's 13F filing for Q4 2015, filed 16 Feb 2016.